← All organizations

Icosavax, Inc.

For profit

Also known as: Icosavax, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 10, 2024

Acquired by AstraZeneca on Dec 12, 2023

Timeline

2010s

Jan 1, 2017
Icosavax, Inc.— Founded

2020s

Dec 12, 2023
AstraZeneca— Acquired By

Drugs by trial phase (4 distinct, 3 trials)

Phase 2 (1 own, 0 via acquisition)

ivx-a12

Phase 1 (3 own, 0 via acquisition)

Recent trials (3)

NCT06481579Lead sponsorPhase 2Jun 10, 2024
NCT05903183Lead sponsorPhase 2May 15, 2023
NCT05664334Lead sponsorPhase 1Sep 21, 2022

Details

Founded: Seattle, WA, US Jan 1, 2017
Last known activity: Jun 10, 2024